SEC Form 4 · accession 0001127602-16-051875
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · CRL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Richard F Wallman
Director
Period of report
May 10, 2016
Accepted (ET)
May 12, 2016 · 11:16 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001100682
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 10, 2016 | M | 11,990 | $37.81 | A | 27,420 | D | |
| Common Stock | May 10, 2016 | S | 11,990 | $84.00 | D | 15,430 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (Right to Buy) | $37.81 | May 10, 2016 | M | 11,990 | D | Feb 1, 2012 | Feb 1, 2018 | Common Stock | 11,990 | 0 | D |
Explanation of responses
- F1This sale occurred pursuant to a 10b5-1 Trading Plan.